What we call ourselves, and how others refer to us, matters. This is perhaps nowhere more important than […]
An update of the National Institute for Health and Care Excellence (NICE) guidelines for diagnosis and management of […]
Surveys uncovers findings pre- and post-pandemic
Final appraisal determination recommends anti-VEGF treatment for NHS use
New company will focus on developing bispecific antibodies for rare bleeding disorders
British drugmaker will acquire Alexion for approximately $39bn
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST
Updated Date: Tue, 08 Dec 2020 00:00:00 EST